Pihlajalinna Oyj

Pihlajalinna Oyj has a debt-to-equity ratio of 1.59, indicating a relatively high level of leverage, and a current ratio of 0.73, suggesting potential liquidity constraints. The company's liquidity position is assessed as medium, with a key flag noting that net cash is negative after subtracting total debt. The company's profitability is reflected in a return on equity (ROE) of 19.72% and a return on assets (ROA) of 6.28%. These figures are compared against the industry's preferred metrics, where ROE and ROA are key indicators of financial performance. The ROE is notably strong, suggesting efficient use of equity, while the ROA is moderate, indicating room for improvement in asset utilization. Pihlajalinna Oyj operates in two segments: Private Clinics and Specialized Care (L&E), and Primary and Social Care (P&S). The company's geographic exposure is primarily within Finland, with no significant international operations disclosed. The revenue concentration is not specified, but the company's operations are diversified across different healthcare services. The company's growth trajectory is influenced by its operating cash flow of 75.56 million EUR and free cash flow of 66.98 million EUR. The capital expenditure of -16.51 million EUR indicates a reduction in investment in physical assets. The outlook for the current fiscal year and the next fiscal year is not explicitly provided, but the company's financial performance suggests a stable growth path. The risk assessment for Pihlajalinna Oyj includes a medium liquidity risk and a low dilution risk. The company's debt structure and liquidity position are key factors in its risk profile. The dilution potential is low, and no significant adjustments have been applied to the valuation metrics. Recent events and filings for Pihlajalinna Oyj include analyst estimates for price targets and recommendations. The mean price target is 13.03 EUR, with a median of 12.50 EUR, and the mean recommendation is 1.80, indicating a generally positive outlook from analysts.